Literature DB >> 21990358

Reversible major histocompatibility complex I-peptide multimers containing Ni(2+)-nitrilotriacetic acid peptides and histidine tags improve analysis and sorting of CD8(+) T cells.

Julien Schmidt1, Philippe Guillaume, Melita Irving, Petra Baumgaertner, Daniel Speiser, Immanuel F Luescher.   

Abstract

MHC-peptide multimers containing biotinylated MHC-peptide complexes bound to phycoerythrin (PE) streptavidin (SA) are widely used for analyzing and sorting antigen-specific T cells. Here we describe alternative T cell-staining reagents that are superior to conventional reagents. They are built on reversible chelate complexes of Ni(2+)-nitrilotriacetic acid (NTA) with oligohistidines. We synthesized biotinylated linear mono-, di-, and tetra-NTA compounds using conventional solid phase peptide chemistry and studied their interaction with HLA-A*0201-peptide complexes containing a His(6), His(12), or 2×His(6) tag by surface plasmon resonance on SA-coated sensor chips and equilibrium dialysis. The binding avidity increased in the order His(6) < His(12) < 2×His(6) and NTA(1) < NTA(2) < NTA(4), respectively, depending on the configuration of the NTA moieties and increased to picomolar K(D) for the combination of a 2×His(6) tag and a 2×Ni(2+)-NTA(2). We demonstrate that HLA-A2-2×His(6)-peptide multimers containing either Ni(2+)-NTA(4)-biotin and PE-SA- or PE-NTA(4)-stained influenza and Melan A-specific CD8+ T cells equal or better than conventional multimers. Although these complexes were highly stable, they very rapidly dissociated in the presence of imidazole, which allowed sorting of bona fide antigen-specific CD8+ T cells without inducing T cell death as well as assessment of HLA-A2-peptide monomer dissociation kinetics on CD8+ T cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21990358      PMCID: PMC3308881          DOI: 10.1074/jbc.M111.283127

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

Review 1.  Streptavidin-biotin binding energetics.

Authors:  P S Stayton; S Freitag; L A Klumb; A Chilkoti; V Chu; J E Penzotti; R To; D Hyre; I Le Trong; T P Lybrand; R E Stenkamp
Journal:  Biomol Eng       Date:  1999-12-31

2.  Class I negative CD8 T cells reveal the confounding role of peptide-transfer onto CD8 T cells stimulated with soluble H2-Kb molecules.

Authors:  Eckart Schott; Nicolas Bertho; Qing Ge; Madelon M Maurice; Hidde L Ploegh
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-08       Impact factor: 11.205

3.  Soluble peptide-MHC monomers cause activation of CD8+ T cells through transfer of the peptide to T cell MHC molecules.

Authors:  Qing Ge; Jennifer D Stone; M Todd Thompson; Jennifer R Cochran; Mia Rushe; Herman N Eisen; Jianzhu Chen; Lawrence J Stern
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-08       Impact factor: 11.205

4.  Dissecting TCR-MHC/peptide complex interactions with A2/peptide multimers incorporating tumor antigen peptide variants: crucial role of interaction kinetics on functional outcomes.

Authors:  Valérie Dutoit; Philippe Guillaume; Jean-Charles Cerottini; Pedro Romero; Danila Valmori
Journal:  Eur J Immunol       Date:  2002-11       Impact factor: 5.532

5.  BIACORE analysis of histidine-tagged proteins using a chelating NTA sensor chip.

Authors:  L Nieba; S E Nieba-Axmann; A Persson; M Hämäläinen; F Edebratt; A Hansson; J Lidholm; K Magnusson; A F Karlsson; A Plückthun
Journal:  Anal Biochem       Date:  1997-10-15       Impact factor: 3.365

6.  Soluble MHC-peptide complexes induce rapid death of CD8+ CTL.

Authors:  Marek Cebecauer; Philippe Guillaume; Pavel Hozák; Silke Mark; Helen Everett; Pascal Schneider; Immanuel F Luescher
Journal:  J Immunol       Date:  2005-06-01       Impact factor: 5.422

7.  Soluble MHC-peptide complexes containing long rigid linkers abolish CTL-mediated cytotoxicity.

Authors:  Georgi S Angelov; Philippe Guillaume; Marek Cebecauer; Giovanna Bosshard; Danijel Dojcinovic; Petra Baumgaertner; Immanuel F Luescher
Journal:  J Immunol       Date:  2006-03-15       Impact factor: 5.422

8.  Reversible HLA multimers (Streptamers) for the isolation of human cytotoxic T lymphocytes functionally active against tumor- and virus-derived antigens.

Authors:  Julia Neudorfer; Burkhard Schmidt; Katharina M Huster; Florian Anderl; Matthias Schiemann; Gerd Holzapfel; Thomas Schmidt; Lothar Germeroth; Hermann Wagner; Christian Peschel; Dirk H Busch; Helga Bernhard
Journal:  J Immunol Methods       Date:  2007-01-31       Impact factor: 2.303

Review 9.  Tricks with tetramers: how to get the most from multimeric peptide-MHC.

Authors:  Linda Wooldridge; Anna Lissina; David K Cole; Hugo A van den Berg; David A Price; Andrew K Sewell
Journal:  Immunology       Date:  2009-02       Impact factor: 7.397

10.  Interaction between the CD8 coreceptor and major histocompatibility complex class I stabilizes T cell receptor-antigen complexes at the cell surface.

Authors:  Linda Wooldridge; Hugo A van den Berg; Meir Glick; Emma Gostick; Bruno Laugel; Sarah L Hutchinson; Anita Milicic; Jason M Brenchley; Daniel C Douek; David A Price; Andrew K Sewell
Journal:  J Biol Chem       Date:  2005-04-18       Impact factor: 5.157

View more
  13 in total

Review 1.  Evolving Approaches in the Identification of Allograft-Reactive T and B Cells in Mice and Humans.

Authors:  James S Young; Christine McIntosh; Maria-Luisa Alegre; Anita S Chong
Journal:  Transplantation       Date:  2017-11       Impact factor: 4.939

2.  Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation.

Authors:  Jaikumar Duraiswamy; Riccardo Turrini; Aspram Minasyan; David Barras; Isaac Crespo; Alizée J Grimm; Julia Casado; Raphael Genolet; Fabrizio Benedetti; Alexandre Wicky; Kalliopi Ioannidou; Wilson Castro; Christopher Neal; Amandine Moriot; Stéphanie Renaud-Tissot; Victor Anstett; Noémie Fahr; Janos L Tanyi; Monika A Eiva; Connor A Jacobson; Kathleen T Montone; Marie Christine Wulff Westergaard; Inge Marie Svane; Lana E Kandalaft; Mauro Delorenzi; Peter K Sorger; Anniina Färkkilä; Olivier Michielin; Vincent Zoete; Santiago J Carmona; Periklis G Foukas; Daniel J Powell; Sylvie Rusakiewicz; Marie-Agnès Doucey; Denarda Dangaj Laniti; George Coukos
Journal:  Cancer Cell       Date:  2021-11-04       Impact factor: 31.743

Review 3.  Bystander T cells in cancer immunology and therapy.

Authors:  Stefanie L Meier; Ansuman T Satpathy; Daniel K Wells
Journal:  Nat Cancer       Date:  2022-02-28

4.  TCR-ligand dissociation rate is a robust and stable biomarker of CD8+ T cell potency.

Authors:  Mathilde Allard; Barbara Couturaud; Laura Carretero-Iglesia; Minh Ngoc Duong; Julien Schmidt; Gwennaëlle C Monnot; Pedro Romero; Daniel E Speiser; Michael Hebeisen; Nathalie Rufer
Journal:  JCI Insight       Date:  2017-07-20

5.  Production of Class II MHC Proteins in Lentiviral Vector-Transduced HEK-293T Cells for Tetramer Staining Reagents.

Authors:  Richard A Willis; Vasanthi Ramachandiran; John C Shires; Ge Bai; Kelly Jeter; Donielle L Bell; Lixia Han; Tamara Kazarian; Kyla C Ugwu; Oskar Laur; Susana Contreras-Alcantara; Dale L Long; John D Altman
Journal:  Curr Protoc       Date:  2021-02

6.  Analysis, Isolation, and Activation of Antigen-Specific CD4(+) and CD8(+) T Cells by Soluble MHC-Peptide Complexes.

Authors:  Julien Schmidt; Danijel Dojcinovic; Philippe Guillaume; Immanuel Luescher
Journal:  Front Immunol       Date:  2013-07-30       Impact factor: 7.561

Review 7.  Identifying Individual T Cell Receptors of Optimal Avidity for Tumor Antigens.

Authors:  Michael Hebeisen; Mathilde Allard; Philippe O Gannon; Julien Schmidt; Daniel E Speiser; Nathalie Rufer
Journal:  Front Immunol       Date:  2015-11-18       Impact factor: 7.561

8.  Sensitive and frequent identification of high avidity neo-epitope specific CD8 + T cells in immunotherapy-naive ovarian cancer.

Authors:  Sara Bobisse; Raphael Genolet; Annalisa Roberti; Janos L Tanyi; Julien Racle; Brian J Stevenson; Christian Iseli; Alexandra Michel; Marie-Aude Le Bitoux; Philippe Guillaume; Julien Schmidt; Valentina Bianchi; Denarda Dangaj; Craig Fenwick; Laurent Derré; Ioannis Xenarios; Olivier Michielin; Pedro Romero; Dimitri S Monos; Vincent Zoete; David Gfeller; Lana E Kandalaft; George Coukos; Alexandre Harari
Journal:  Nat Commun       Date:  2018-03-15       Impact factor: 14.919

9.  T cell receptor alpha variable 12-2 bias in the immunodominant response to Yellow fever virus.

Authors:  Amandine Bovay; Vincent Zoete; Garry Dolton; Anna M Bulek; David K Cole; Pierre J Rizkallah; Anna Fuller; Konrad Beck; Olivier Michielin; Daniel E Speiser; Andrew K Sewell; Silvia A Fuertes Marraco
Journal:  Eur J Immunol       Date:  2017-12-11       Impact factor: 5.532

Review 10.  Neoantigen-Specific Adoptive Cell Therapies for Cancer: Making T-Cell Products More Personal.

Authors:  Valentina Bianchi; Alexandre Harari; George Coukos
Journal:  Front Immunol       Date:  2020-06-26       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.